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Protein palmitoylation is a reversible lipidmodifi-
cation that regulatesmembrane tethering for key
proteins in cell signaling, cancer, neuronal trans-
mission, and membrane trafficking. Palmitoyla-
tion has proven to be a difficult study: Specifying
consensuses for predicting palmitoylation re-
main unavailable, and first-example palmitoyla-
tion enzymes—i.e., protein acyltransferases
(PATs)—were identified only recently. Here, we
use a new proteomic methodology that purifies
and identifies palmitoylated proteins to charac-
terize the palmitoyl proteome of the yeast
Saccharomyces cerevisiae. Thirty-five new pal-
mitoyl proteins are identified, including many
SNARE proteins and amino acid permeases as
well asmany other participants in cellular signal-
ingandmembrane trafficking.Analysisofmutant
yeast strainsdefective formembersof theDHHC
protein family, a putative PAT family, allows
a matching of substrate palmitoyl proteins to
modifying PATs and reveals the DHHC family to
be a family of diverse PAT specificities responsi-
ble for most of the palmitoylation within the cell.
INTRODUCTION
Palmitoylation or protein S-acylation is the thioesterifica-
tion of fatty acids, usually palmitic acid, to cysteine thiols
(for recent reviews on palmitoylation, see Huang and
El-Husseini, 2005; Smotrys and Linder, 2004). Like the
analogous lipid modifications myristoylation and prenyla-
tion, palmitoylation serves to tether proteins to the cyto-
plasmic surfaces of cellular membranes. Among the pro-
teins that rely on palmitoylation for localized function are
many of the key players in cellular signaling, membrane
trafficking, cancer, and synaptic transmission, includingmany G proteins such as Ras- and Rho-like proteins as
well as the a and g subunits of many heterotrimeric G
proteins; many nonreceptor tyrosine kinases, e.g., Fyn,
Lck, and Yes; and the epithelial nitric oxide synthase
(eNOS). Palmitoylation is distinguished from the other
two tethering modifications, myristoylation and prenyla-
tion, by its reversibility. Reversibility allows for regulation,
and, indeed, rapidly cycling palmitoyl modifications have
been shown to regulate synaptic plasticity (El-Husseini
Ael et al., 2002), b-adrenergic receptor desensitization
(Jones et al., 1997; Moffett et al., 2001; Tu et al., 1997;
Wedegaertner and Bourne, 1994), and the plasma-mem-
brane-localized activity of H- and N-Ras (Rocks et al.,
2005). Palmitoylation also differs from myristoylation or
prenylation in that it is often found to modify transmem-
brane (TM) proteins; thus, the list of palmitoylated proteins
also includes many G protein-coupled receptors, viral-en-
velope proteins, caveolin, and diverse ion channels and
ionotropic neurotransmitter receptors. Although the func-
tion provided by palmitoylation to such TM proteins is not
entirely clear, it may reflect roles in lipid raft and mem-
brane microdomain targeting (Brown and London, 1998;
Zacharias et al., 2002).
Given the prevalence and importance of protein palmi-
toylation, it is surprising howpoorly understood its underly-
ingmechanisms remain.With its occurrence in such awide
spectrum of sequence contexts, consensuses that would
allow palmitoylation to be predicted from sequence have
yet to bedefined. The enzymologyof palmitoylation also re-
mains poorly defined. The first protein acyltransferases
(PATs) were identified only recently, by work in the yeast
Saccharomyces cerevisiae (Lobo et al., 2002; Roth et al.,
2002). The two identified yeast PATs, Akr1 and Erf2-Shr5,
share a common, 50 residue zinc-finger-like sequence,
theDHHCcysteine-rich domain, and together point toward
the wider DHHC protein family as a possible PAT family.
DHHC-family proteins, a collection of polytopic integral
membrane proteins, typically share little or no homology
beyond their defining DHHC domain; yeast has seven
DHHC proteins (including Akr1 and Erf2), while 23 haveCell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc. 1003
been identified from the human genome. Recent analyses
of various yeast and mammalian DHHC proteins generally
support a DHHC protein role in palmitoylation (Ducker
et al., 2004; Fukata et al., 2004; Hou et al., 2005; Huang
et al., 2004; Keller et al., 2004; Smotrys et al., 2005; Swarth-
out et al., 2005; Valdez-Taubas and Pelham, 2005). How-
ever, the extent of this role is called into question by in vitro
demonstrations of DHHC protein-independent palmitoyla-
tion (Dietrich et al., 2004; Dietrich and Ungermann, 2004),
including apparently bona fide palmitoylations that pro-
ceed nonenzymatically in vitro, through direct chemical re-
action of acceptor thiols with palmitoyl-CoA (Duncan and
Gilman, 1996; Leventis et al., 1997; Veit, 2000). Thus, the
overall role of DHHC proteins—and, more generally, of
enzymes—in protein palmitoylation remains uncertain.
Palmitoyl proteins typically are identified through in vivo
[3H]palmitate labeling, a tedious process involving large
amounts of input label, immune precipitation, fluorogra-
phy, and notoriously long autoradiographic exposures
(week- or month-long). With the focus always on individual
proteins, the overall scope of palmitoylation’s use in the
cell remains untested. Below, we describe a new proteo-
mic method that purifies and identifies palmitoylated
proteins. We have applied this method first in the yeast
Saccharomyces cerevisiae toward a comprehensive iden-
tification of the proteins that comprise the yeast palmitoyl
proteome. This approach identifies 12 of the 15 known
palmitoyl proteins plus many new palmitoyl proteins. In
addition, the application of this approach to mutant yeast
strains deficient for different DHHC-family proteins has
allowed us to both gauge the impact of DHHC proteins
on palmitoylation and match the palmitoyl-protein sub-
strates to cognate modifying DHHC PATs. Our results
demonstrate the DHHC protein family to be a family of
diverse PAT specificities that mediate the bulk of the
protein palmitoylation within the cell.
RESULTS AND DISCUSSION
Purification and Identification of Yeast Palmitoyl
Proteins
Our protocol for purifying palmitoyl proteins from complex
protein extracts is a proteomic scaling of the acyl-biotinyl
exchange (ABE) chemistry of Drisdel and Green (2004).
The ABE substitution of biotin for protein palmitoyl modifi-
cations consists of three sequential chemical steps: (1)
blockade of free thiols with N-ethyl maleimide (NEM), (2)
cleavage of palmitoylation thioester linkages with hydrox-
ylamine, and finally (3) the marking of the cysteinyl thiols,
newly exposed by hydroxylamine with a thiol-specific bio-
tinylation reagent. Proteins from total yeast membranes
were subjected to ABE, and the resulting biotinylated
proteins were affinity purified by streptavidin agarose. As
a control, half of theprotein extractwasprocessed through
a parallel protocol that omitted hydroxylamine. The final
two purified samples—the experimental +hydroxylamine
(EXP) sample and the controlhydroxylamine (CON) sam-
ple—were subjected to gel analysis (Figure 1A). Proteins1004 Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc.that are common to both samples presumably are purified
nonspecifically due either to inappropriate biotinylation or
nonspecific streptavidin binding. Proteins unique to the
EXP sample (Figure 1A, arrows) should represent purified
palmitoyl proteins.
MudPIT (multi-dimensional protein identification tech-
nology), a robust, tandem-MS-based proteomic method-
ology capable of identifying thousands of proteins per run
(Link et al., 1999;Washburn et al., 2001), was used to iden-
tify EXP and CON sample proteins. Candidate palmitoyl
proteins were defined as proteins with exclusive, or sub-
stantially higher, EXP versus CON sample representa-
tions. To compare the relative abundance of each protein
in the two samples, we relied on per-protein spectral
counts—i.e., the number of peptide identifications (includ-
ing redundant identifications) linked to each protein iden-
tification—as a roughmetric of relative protein abundance
(Liu et al., 2004). Combined data fromMudPIT analyses of
four paired EXP-CON samples (see Table S1 in the Sup-
plemental Data available with this article online) are graph-
ically represented in Figure 1B: For each protein, averaged
EXP sample spectra counts are plotted on the x axis
against averaged CON sample spectra counts on the y
axis. The vast majority of the identified proteins show sub-
stantial representations in both the CON and EXP samples
(Figure 1B, gray dots); these proteins tend to be highly
abundant proteins (e.g., ribosomal proteins, chaperonins,
etc.; Ghaemmaghami et al., 2003) that likely contaminate
both samples nonspecifically. All 15 known yeast palmi-
toyl proteins were detected (Figure 1B, red dots); 12 of
the 15 clustered near the x axis with significantly higher
EXP versus CON sample representations. The other pro-
teins clustering along the x axis with the known palmitoyl
proteins (Figure 1B, blue dots) are investigated below as
new palmitoyl-protein candidates.
Proteins were ranked according to both their EXP sam-
ple abundance and their EXP/CON spectra count ratio (the
70 most abundant proteins with EXP/CON ratios greater
than 5.5 are listed and described in Table S2). To cull false
positives, proteins were individually tested for palmitoyla-
tion by either the ABE protocol or the standard [3H]palmi-
tate in vivo labeling protocol (example tests are shown in
Figure S1, with overall results of this testing summarized
in Table S2). Many of the false positives appear to be sta-
tistical anomalies, i.e., contaminant proteins that fail to be
subtracted due to chance CON sample underdetection.
As the ABE chemistry detects palmitoylation through de-
tection of the thioester linkage, another false-positive
class are proteins that use thioester linkages for biochem-
istries other than palmitoylation. Indeed, the two proteins
most prominently detected in the proteomic analysis, Lat1
and Pdx1 (Table S2), both fall into this category; both are
subunits of the mitochondrial pyruvate dehydrogenase
complex, and both utilize covalently bound lipoic-acid
prosthetic groups to transiently accept acetyl moieties in
thioester linkage (for pyruvate decarboxylation). Pdx1 is
robustly labeled by the ABE protocol (data not shown)
but shows no hint of in vivo labeling by [3H]palmitate
Figure 1. Proteomic Analysis
(A) Electrophoretic analysis of purified hydroxylamine (CON) and +hydroxylamine (EXP) samples. One percent of total purified samples were
subjected to SDS-PAGE and silver staining. EXP sample-specific proteins are indicated by arrows.
(B) Graphical depiction of MS analysis. For each identified protein, averaged and normalized EXP sample spectral counts from four wild-type samples
(x axis) is plotted against averaged, normalized CON sample spectral counts (y axis). Shown at right is an expanded view of the indicated portion.
Known palmitoyl proteins are indicated in red; the new candidate palmitoyl proteins are blue. Proteins with substantial representations from both
the EXP and CON samples are gray. Note that 3 of the 15 known palmitoyl proteins fail to cluster with other known palmitoyl proteins, being detected
either by low spectral count numbers (Ykt6) or from both EXP and CON samples (Hem14 and Tub1). See Table S1 for supporting MS/MS data.(Figure S1). Three other prominently detected proteins,
Gcv3, Acp1, and Ubc1, also use thioesters in their enzy-
matic mechanism and thus also likely fall into this same
false-positive category (Table S2). Given the positive
ABE detection of these thioester-using impostors, we
have relied predominantly on in vivo [3H]palmitate labeling
as the primary test for validating palmitoylation; palmitoyla-
tion was confirmed for 26 of the candidate proteins by
this test (Figure S1). Testing results for all of the top 70
candidate proteins are summarized in Table S2.
New Palmitoyl Proteins
Overall, our proteomic analysis detected 47 palmitoyl pro-
teins: 12 of the 15 known palmitoyl proteins plus 35 new
palmitoyl proteins (Figure 2). The new palmitoyl proteins
span a wide range of cellular functions (for protein descrip-
tions, see Table S2), including three G proteins (Gpa2,
Rho2, and Rho3), three Golgi-localized mannosyltrans-
ferases (Mnn1, Mnn10, and Mnn11), the plasma-mem-
brane-localized phosphatases Psr1 and Psr2, the phos-
phoinositol-4-kinase Lsb6, and the yeast sphingosine
kinase homolog Lcb4. Also prominently detected as palmi-
toylated were many SNARE proteins (mediators of vesicu-
lar fusion), with 8 of the 23 yeast SNARE proteins being
detected as palmitoylated, as well as a number of amino
acid permeases (AAPs, the plasma-membrane-localized
mediators of amino acid import).Many of the newpalmitoyl
proteins have cysteines positioned in typical palmitoylation
contexts—e.g., proximal to motifs for either N-terminal
myristoylation or C-terminal prenylation—or, for TM pro-
teins, cysteines near predicted TM domain (TMD) bound-
aries (Figure 2). Strikingly, all 13 palmitoyl proteins within
the single-TMD category, a group which includes the eightSNARE proteins, have cysteines that map cytoplasmically
adjacent to their TMD (Figure 2).
SNARE Proteins
Eight of the twenty-three yeast SNARE proteins are identi-
fied here as palmitoylated (Figure 2); all eight have juxta-
TMD cysteines as likely palmitoyl acceptors (Figure 2).
The 15 SNAREs not detected by our analysis conspicu-
ously lack such cysteines. While palmitoylation had been
previously demonstrated for two of the eight palmitoylated
SNAREs—namely for the redundant plasma-membrane
v-SNAREs Snc1 and Snc2 (Couve et al., 1995)—this wide-
spreadyeastSNAREpalmitoylation reportedbothhereand
in a recent paper (Valdez-Taubas and Pelham, 2005) was
not anticipated. SNARE palmitoylation likely is not a
yeast-limited phenomenon: Cursory inspection of mam-
malian SNARE sequences (Bock et al., 2001) finds a high
proportion (15 of 36) also with cysteines cytoplasmically
adjacent to their membrane-anchoring TMD. Thus, some
function for SNARE palmitoylation has been conserved
through evolution. Palmitoylation may serve to target
SNAREs to lipid rafts or, alternatively, could regulateor par-
ticipate more directly in the membrane fusion event itself.
Thoughall eight SNAREswith juxta-TMDcysteineswere
detected by our analysis, one palmitoylated yeast SNARE,
Ykt6 (Dietrich et al., 2005; Fukasawa et al., 2004), was
missed. Ykt6 is an atypical SNARE: It lacks a TMD and in-
stead relies entirely on C-terminal lipidation, dual prenyla-
tion-palmitoylation, for a regulated anchoring to the donor
bilayer; at any given point in time, only a fraction of the Ykt6
protein is palmitoylated and hence membrane anchored
(Dietrich et al., 2005). Our poor detection of Ykt6 (low-level
detection in only one of the four MudPIT runs; Table S1)
may indicate low fractional palmitoylation for Ykt6.Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc. 1005
Figure 2. Yeast Palmitoyl Proteins
Palmitoyl proteins, both new and known, de-
tected by the MS analysis are classed by pres-
ence or absence of predicted TMDs and by
positioning of likely palmitoyl-accepting cyste-
ines. Known palmitoyl proteins are shown in
brown; new palmitoyl proteins are shown in
black. For each of the listed proteins, Table S2
provides a full summary of the evidence sup-
porting palmitoylation. Proteins lacking strong
independent confirmation of palmitoylation
are shown in green. Four proteins for which
palmitoylation has been confirmed in recent
published reports (Harashima and Heitman,
2005; Kihara et al., 2005; Valdez-Taubas and
Pelham, 2005) are shown in red. At right,
TMD-proximal sequences are shown for the
indicated proteins.Amino Acid Permeases
AAPs, polytopic membrane proteins with 12 predicted
TMDs, are the plasma-membrane-localized importers of
amino acids; 25 AAPs with different transport specificities
are identifiable from the yeast genome. Intriguingly, the
four AAPs detected as palmitoylated in our initial analy-
sis—i.e., Tat1, Gnp1, Sam3, and Hip1—all have the identi-
cal C-terminal sequence Phe-Trp-Cys (Figure 3A). A fifth
AAP, Bap2, also with the C-terminal Phe-Trp-Cys se-
quence, was identified by the MS analysis at a somewhat
lower significance level (ranking below the top 70 candi-
dates at position 90). Cys-to-Ser mutation of the C-termi-
nal cysteines for Tat1, Gnp1, Hip1, and Bap2 fully abol-
ishes palmitoylation (Figure 3B), indicating service of the
C-terminal cysteines as the sole palmitoyl acceptors. Six
additional AAPs not detected by our MS analysis also
have C-terminal cysteines: Agp1, Bap3, Gap1, and Tat2
have the C-terminal Phe-Trp-Cys sequence, while Mmp1
ends with Phe-Phe-Cys and Mup3 with Cys-Leu-Cys
(Figure 3A); the 14 other yeast AAPs lack C-terminal cyste-
ines. The lack of MS detection for these other AAPs with
C-terminal cysteines may reflect the low expression ex-
pected for many AAPs in the rich culture conditions used
for preparation of the proteomic extracts; indeed, as
shown below, with forced AAP expression from the GAL1
promoter, we do find additional members of this AAP
sequence class to be palmitoylated. As suggested above
for the SNARE proteins, palmitoylation also may serve to
regulate function and/or sorting of many yeast AAPs.
Rho Proteins
Twoof the six yeast Rhoprotein actin regulators, Rho2 and
Rho3, are identified as being palmitoylated (Figure 2). The
C-terminal sequence of Rho2, -Cys-Cys-Ile-Ile-Leu, is
typical of dually prenylated-palmitoylated proteins, having1006 Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc.a likely palmitoyl-accepting cysteine proximal (in this case,
adjacent) to a C-terminal -CaaX prenylation consensus in
which C represents cysteine, aa represents any two ali-
phatic amino acids, and X represents the amino acid spec-
ifying farnesylation or geranylgeranylation (Figure 3C). The
other five yeast Rho proteins also have -CaaX prenylation
consensuses but lack proximal cysteines for palmitoyla-
tion (Figure 3C). However, four of the five have proximal
polybasic sequences that are thought to stabilize mem-
brane attachments of proteins with single-lipid tethers
through electrostatic interaction with anionic phospholipid
head groups (Resh, 1999). The exception is Rho3, which
lacks both proximal cysteines and polybasic sequences
(Figure 3C). Looking farther afield within the Rho3 se-
quence to account for its palmitoylation, one does find
a cysteine at the Rho3 N terminus that maps to a unique
Rho3 N-terminal extension (Figure 3C). Mutation of this
cysteine (i.e., C5S) does indeed abolish Rho3 palmitoyla-
tion (Figure 3D). Furthermore, Rho3 palmitoylation also is
abolished by mutation of the C-terminal prenyl acceptor
(i.e., C228S) (Figure 3D), consistent with the dogma for du-
ally prenylated-palmitoylated proteins that palmitoylation
requires prior prenylation (Dunphy and Linder, 1998; el-
Husseini Ael and Bredt, 2002; Smotrys and Linder, 2004).
Thus, our results indicate that Rho3 is a unique example
of a dually prenylated-palmitoylated protein—prenylated
at itsC terminus andpalmitoylated at itsN terminus. Simul-
taneous tethering of both N andC termini could be accom-
modated by the conserved Rho protein structure: Both
N and C termini emerge from the same face of the folded
protein and are spatially proximal (Ihara et al., 1998; Wei
et al., 1997). While the majority of mammalian Rho/Rac-
family actin regulators appear to tether to membranes ex-
clusively through C-terminal lipidations and polybasic se-
quences, a few, like yeast Rho3, have cysteine-containing
Figure 3. Palmitoylation Acceptor Sites
(A) Consensus elements for the 11 amino acid
permeases (AAPs) with C-terminal cysteines.
The five AAPs identified as palmitoylated by
the proteomic analysis are indicated with aster-
isks.
(B) AAP C-terminal Cys is required for palmi-
toylation. For the indicated AAPs, palmitoyla-
tion of both the wild-type AAP (wt) and the
C-terminal Cys-to-Ser mutant version (FWS)
was assessed using a scaled-down version of
the acyl-biotinyl exchange (ABE) protocol
(Supplemental Experimental Procedures). To
facilitate this analysis, AAPs were N-terminally
FLAG/HA epitope tagged and overexpressed
from the GAL1 promoter (2 hr expression pe-
riod). Following ABE, AAPs were anti-FLAG
immunoprecipitated and then blotted for bioti-
nylation (a-biotin; indicative of palmitoylation)
or overall recovery (a-HA).
(C) Membrane tethering sequences of yeast
Rhoproteins. TheC-terminal 13aminoacid res-
idues of the six yeast Rho proteins are shown.
CaaX prenylation motifs and polybasic domains
are red, and likely palmitoyl-accepting cyste-
ines are highlighted in black.
(D)N-terminal Rho3 palmitoylation requires prior C-terminal prenylation.Cells expressingwild-type or the two indicatedmutant Rho3 proteins from the
GAL1 promoter (2 hr expression period) were labeled with [3H]palmitic acid. Immunoprecipitated Rho3 was analyzed for both label incorporation (top
panel) and Rho3 protein recovery (bottom panel). The 43HA/FLAG epitope tag used for this analysis (for immunoprecipitation and for Western detec-
tion) was inserted internally within the RHO3 ORF, between codons Ala217 and Thr218 (14 codons from the RHO3 stop codon), to avoid disrupting
N- and C-terminal lipidation sites.N-terminal sequences suggestive of possible dual N-ter-
minal tethering: most notably RhoJ, but also RhoU,
Rnd1, Rnd2, and Rnd3.
Analysis of DHHC PAT-Deficient Strains
Weandothers have suggested that theDHHCprotein fam-
ily may function as a diverse family of PAT specificities
(Lobo et al., 2002; Roth et al., 2002). To assess overall
DHHC protein involvement in palmitoylation, we have ap-
plied our proteomic method to mutant yeast strains either
singly or multiply deficient for the seven yeast DHHC
proteins. Proteins relying on particular DHHC proteins for
their palmitoylation were expected to be lost from the
palmitoyl proteomes of the DHHC protein-deficient strain.
Palmitoyl-proteome profiles deriving from MudPIT anal-
yses of nine different DHHC mutant yeast strains are
graphically summarized in Figure 4. Palmitoyl proteins
underrepresented in the mutant strain profiles relative to
wild-type are shaded red: Proteins fully lost (i.e., >20-fold
underrepresentations relative to wild-type) are bright red,
while proteins having more subtle underrepresentations
are indicated with corresponding intermediate red shad-
ings (Figure 4). To improve the statistical quality of this
analysis, focus was limited to just the 30most prominently
detected palmitoyl proteins, i.e., those detected by the
highest spectra count values.
Substrates for the Akr1, Erf2-Shr5, and Swf1 PATs
Strains individually deficient for Akr1, Swf1, or Erf2 were
profiled first. For akr1D cells (Figure 4, row 1), significantunderrepresentations were found for six proteins: the
two known Akr1 substrates, Yck1 and Yck2 (Roth et al.,
2002); Akr1 itself; andMeh1, Ypl199c, and Ykl047w.While
the loss of Akr1 from the profile is trivial (cells are akr1D),
Meh1, Ypl199c, and Ykl047w may represent new Akr1
substrates; indeed, all three, when individually tested,
were found to depend on Akr1 for palmitoylation (Fig-
ure 5A). In addition, two other palmitoyl proteins that
ranked somewhat lower in our proteomic analysis, Sna4
and Ypl236c, also showed Akr1-dependent palmitoylation
(Figure 5A). While comparison of these putative Akr1 sub-
strates reveals no obvious consensus motif, there are
some loose commonalities: Most, but not all, are soluble
proteins that tether to bilayers solely through either N- or
C-terminal palmitoylation (Figure 5A).
The yeast Ras PAT, like the recently identified mamma-
lian H- and N-Ras PAT (Swarthout et al., 2005), appears to
be composed of two subunits: the DHHC protein Erf2 and
the non-DHHC protein Shr5 (Lobo et al., 2002). While Erf2-
Shr5 mediates palmitoylation of Ras2, in the absence of
this PAT—i.e., in erf2D, shr5D, or erf2D shr5D cells—sub-
stantial residual Ras2 palmitoylation continues (Bartels
et al., 1999; Lobo et al., 2002), indicating that Erf2-Shr5-
independent mechanisms also are capable of Ras2 palmi-
toylation. Consistent with this, our profiles of the erf2D
and shr5D cell palmitoyl proteomes find Ras2, as well as
the homologous and functionally redundant Ras1, to be
underrepresented but not fully lost (Figure 4, rows 2 and
3, subtle red shadings). In erf2D cells, underrepresenta-
tions of 4.5- and 4-fold were found for Ras1 and Ras2,Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc. 1007
Figure 4. Palmitoyl-Proteome Profiles of Different DHHC Protein-Deficient Strains
For the30 top-rankingpalmitoyl proteins, EXPsample representations (basedonnormalized spectral counts; seeTableS3 for supportingMS/MSdata)
from thedifferentmutant strainswere compared to averagedEXP representationsderived from the fourwild-typeMS/MS runs. The relevant genotypes
of the different mutant strains are indicated at left: wild-type alleles (+), deletion alleles (D), or depletion alleles (red downward arrow). Proteins with
20-fold or greater mutant strain underrepresentations are depicted as red, with intermediate levels of underrepresentation converted to intermediate
shadings of red as described (Supplemental Experimental Procedures). Similarly, proteins with mutant sample overrepresentations are depicted by
shadings of green. (Subtle green shadings are faintly apparent for only a few boxes within this matrix.) For strains utilizingGAL1-driven ERF2 or SWF1
depletion alleles, the depletion timeperiod (period of growth on glucosemedium) is indicated at right. The rownumbers in yellow at left allow the results
from individual strains to be referenced from the text. An EXP sample from the isogenicwild-type parent strain was analyzed as a control (row 11). Note
that someof the profiled strains harbor the akr1-suppressing lys2D::YCK2(CCIIS) allele (as indicated). The substantial Yck2 palmitoylation that is found
to persist in some of the profiled akr1D strains (e.g., row 7) likely reflects ongoing Akr1-independent palmitoylation of the Yck2(CCIIS) mutant.respectively, while 4.5- and 3-fold underrepresentations
were found for shr5D cells (see Table S3 for supporting
MS data). Similar 3- to 6-fold underrepresentations in
erf2D and/or shr5D cells also are apparent for other palmi-
toyl proteins (Figure 4, rows 2 and 3), suggesting that
these proteins also may partially rely on Erf2-Shr5 for
palmitoylation; indeed, for Gpa2, Rho2, and Rho3,
Erf2-dependent palmitoylation has been confirmed (Fig-
ure 5B). Interestingly, all of the nine proteins implicated
to date as likely Erf2-Shr5 substrates are predicted to be
heterolipidated, being either C-terminally prenylated-pal-
mitoylated (Ras1, Ras2, Ste18, Ycp4, and Rho2), N-termi-
nally myristoylated-palmitoylated (Gpa1, Psr1, Gpa2), or
(in the case of Rho3) C-terminally prenylated and N-termi-
nally palmitoylated (Figure 5B).
While none of the seven DHHC genes is individually re-
quired for yeast cell viability, a significant growth impair-
ment was found to be associated with the swf1D allele
(A.F.R. and N.G.D., unpublished data). Therefore, rather
than profiling a swf1D strain, we opted instead to profile
aGAL1-SWF1 strain that has the chromosomal regulatory
sequences upstream of the SWF1 ORF replaced by the
regulatable GAL1 promoter. The GAL1-SWF1 allele is
conditional:GAL1-SWF1 cells grow normally on galactose1008 Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc.medium and show impaired growth following a prolonged
period of Swf1 depletion instituted through glucose-medi-
ated repression of the GAL1 promoter. Following deple-
tion periods of 24 hr or 72 hr, underrepresentations were
found for many of the top palmitoyl proteins in the
GAL1-SWF1 strain. Consistent with a recent report that
implicated Swf1 in SNARE protein palmitoylation (Val-
dez-Taubas and Pelham, 2005), significant underrepre-
sentations were seen for many of the palmitoylated
SNARE proteins (Figure 4, rows 4 and 5). Other proteins
showing evidence of Swf1-dependent palmitoylation in-
clude the three mannosyltransferases, Mnn1, Mnn10,
and Mnn11, as well as the yeast prion induction protein
Pin2. Like the SNAREs, these other proteins all have
juxta-TMD mapping cysteines (Figure 2), suggesting
a Swf1 preference for substrates of this type. For the
Sso1 and Tlg1 SNARE proteins and themannosyltransfer-
ase subunit Mnn11, Swf1-dependent palmitoylation has
been confirmed in individual tests (Figure 5C).
Pfa4: A New PAT for AAP Palmitoylation
Given the precedent of Erf2-Shr5-independent palmi-
toylation for Ras2 (Bartels et al., 1999; Lobo et al., 2002),
we were concerned that many other palmitoyl proteins
Figure 5. DHHC PAT-Dependent Palmitoylation
For the indicated proteins, palmitoylation in the wild-type strain context (+) was compared with that in the indicated DHHC gene-deletion strain con-
text (D): akr1D (A), erf2D (B), or swf1D (C). Palmitoylation was assessed by the small-scale ABE protocol as described for Figure 3B. The tested pro-
teins were expressed from the GAL1 promoter and were either N- or C-terminally tagged with the dual HA/FLAG epitope tag (see Table S2). For (A)
and (B), putative Akr1 and Erf2-Shr5 substrates are listed and sequences surrounding likely palmitoyl-accepting cysteines are shown. Note that Sna4
and Meh1 are unique among the putative Akr1 substrates in that Sna4 has two predicted TMDs and Meh1 is predicted to be heterolipidated: myr-
istoylated in addition to palmitoylated. The asterisk marks a nonspecific band that crossreacts with the anti-biotin IgG.might also rely on the actions of multiple, overlapping
PATs. Much of our analysis, therefore, has concentrated
on strains with multiple DHHC gene deletions. Thus, an
akr2D pfa3D pfa4D pfa5D strain deleted for four previously
uncharacterized DHHC genes was profiled. Only one of
the top palmitoyl proteins was found to fully drop out,
this being the tryptophan permease Tat1 (Figure 4, row
6). To analyze the individual contributions of the four
DHHC proteins deficient in this strain, Tat1 palmitoylation
was assessed in strains individually deleted for the four
DHHC genes. While the akr2D, pfa3D, or pfa5Dmutations
werewithout effect, in pfa4D cells, Tat1 palmitoylationwas
fully abolished (Figure 6A). To see whether Pfa4might play
a more general role in AAP palmitoylation, eight additional
AAPs were examined for palmitoylation in wild-type and in
pfa4D cells (Figure 6B). This survey included, in addition to
three AAPs that were shown above to palmitoylated
(Gnp1, Hip1, and Bap2), five AAPs of unknown palmitoyla-
tion status. Three of the five, Tat2, Agp1, and Gap1, have
C-terminal Phe-Trp-Cys sequences (Figure 3A), while the
other two, Lyp1 and Can1, do not. The results nicely
extend prior results: The three Phe-Trp-Cys-containing
AAPs are found to be palmitoylated, while the two lacking
this motif are not (Figure 6B). Furthermore, for all eight of
the palmitoylated AAPs, palmitoylation is found to be fully
Pfa4 dependent (Figure 6B). Thus, like SNARE protein
palmitoylation, AAP palmitoylation also has a dedicated
PAT, Pfa4. These palmitoylated AAPs represent the first
Pfa4 substrates and allow Pfa4 to be grouped with Akr1,Erf2-Shr5, Swf1, and the recently characterized Pfa3
(Smotrys et al., 2005) as a member of the yeast DHHC
PAT family; five of the seven yeast DHHC proteins now
have been directly linked to palmitoylation.
Overlapping DHHC PAT Functionality
Though all seven DHHC gene deletions are individually
nonessential, strain inviabilities are encountered with cu-
mulative DHHC gene deletion. For instance, the viable
akr2D pfa3D pfa4D pfa5D strain can sustain introduction
of the akr1D allele only in the presence of the akr1 sup-
pressor lys2D::YCK2(CCIIS). The Yck2(CCIIS) mutant
expressed from lys2D::YCK2(CCIIS) has the Yck2 C-ter-
minal, palmitoyl-accepting Cys-Cys dipeptide replaced by
the five C-terminal residues of Ras2, i.e., Cys-Cys-Ile-Ile-
Ser; like Ras2, Yck2(CCIIS) is farnesylated, palmitoylated,
and trafficked to the plasma membrane independently of
Akr1 function (Roth et al., 2002). lys2D::YCK2(CCIIS) re-
stores casein kinase activity to the akr1D cell plasma
membrane and thereby suppresses a variety of akr1-
associated phenotypes, including its associated growth
defect (Y. Feng and N.G.D., unpublished data).
Analysis of the 5-fold-deleted akr1D akr2D pfa3D pfa4D
pfa5D strain finds significant underrepresentations for
many of the top palmitoyl proteins (Figure 4, row 7). In
addition to the expected loss of Akr1 and Pfa4 substrates,
underrepresentations also are seen for many proteins that
retain significant palmitoylation in both the akr1D and the
akr2D pfa3D pfa4D pfa5D parental strains (Figure 4, rowsCell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc. 1009
Figure 6. Pfa4-Dependent AAP Palmitoylation
Palmitoylation of the indicated AAPs was assessed by the small-scale ABE protocol as described for Figure 3B.
(A) Deconvolution of the DHHC protein requirement for Tat1 palmitoylation.
(B) Pfa4-dependent palmitoylation for the Phe-Trp-Cys-containing AAPs.1 and 6). For these proteins, namely Lcb4, Vac8, Yck3, and
Lsb6, Akr1 likely acts redundantly with one (or several) of
the other DHHC proteins deleted, i.e., with either Akr2,
Pfa3, Pfa4, or Pfa5. A recent report found palmitoylation
of the sphingosine kinase Lcb4 to partially require Akr1
function; Lcb4 palmitoylation was reduced by about
60%–80% in akr1Dcells (Kihara et al., 2005). Close inspec-
tion of our data finds a subtle, 2.6-fold reduction for Lcb4
representation in the akr1D cell sample (Figure 4, row 1
and Table S3). Building on this result, the present finding
of abolished Lcb4 palmitoylation in the 5-fold-deleted
strain (Figure 4, row 7), indicates that, in addition to Akr1,
one or more of four other DHHC proteins—i.e., Akr2,
Pfa3, Pfa4, and/or Pfa5—also can participate in Lcb4
palmitoylation. Similarly, a recent report found the palmi-
toylation of the vacuolar armadillo repeat protein Vac8 to
partially depend on Pfa3 (Hou et al., 2005; Smotrys et al.,
2005); coupling this to the current MS result (Figure 4,
row7) implicates Akr1 as thePAT responsible for the resid-
ual Vac8 palmitoylation that persists in pfa3D cells.
Our finding that Vac8 palmitoylation is fully DHHC PAT
dependent contrasts with a prior report that found Vac8
palmitoylation to be fully DHHC PAT independent in vitro
(Dietrich et al., 2004): In vitro, the atypical SNAREYkt6 suf-
fices to mediate Vac8 palmitoylation; indeed, just the 140
residue Ykt6 longin domain, which was also found to have
binding affinity for palmitoyl-CoA and palmitic acid, suf-
fices to promote palmitoylation (Dietrich et al., 2004).
However, a caveat accompanying all in vitro demonstra-
tions of protein palmitoylation is the well-known capacity
of palmitoyl-CoA for direct chemical modification of sub-
strate cysteines; indeed, in vitro, nonenzymatic palmi-
toylations have been demonstrated for a number of differ-
ent proteins (Duncan and Gilman, 1996; Leventis et al.,
1997; Veit, 2000). Consistent with view in which Ykt6 acts
to augment a basal level of direct chemical palmitoylation,
significant Vac8 palmitoylation is reported even in the
absence of added Ykt6 (Dietrich et al., 2004). Efforts to
investigate Ykt6 participation in palmitoylation in vivo are
hampered by the YKT6 requirement for yeast cell viability.
Deficiencies for Swf1 and Erf2 could be introduced into
the 5-fold-deleted akr1D akr2D pfa3D pfa4D pfa5D strain
only as conditional-depletion alleles. Two strains were
constructed by introducing either the GAL1-SWF1 or the
GAL1-ERF2 depletion allele into the 5-fold-deleted strain.1010 Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc.Profiles of the resultingGAL1-SWF1 6-fold-deficient strain
(Figure 4, rows 9 and 10) yielded essentially the result
expected for a simple summation of the previous GAL1-
SWF1 strain result (Figure 4, rows 4 and 5) with the
5-fold-deleted strain result (Figure 4, row 7). In contrast,
analysis of the GAL1-ERF2 6-fold-deficient strain found
that three proteins, namely Gpa1, Psr1, and Ste18, that
had shown partial underrepresentations in the erf2D strain
(Figure 4, row 2) were now fully lost from the 6-fold-defi-
cient strain profile (Figure 4, row 8). Thus, overlapping
PAT substrate specificities are again implicated—in this
instance, an overlap of Erf2-Shr5 with one (or several) of
the five other DHHC activities deleted in this strain. The
five other putative Erf2-Shr5 substrates, namely Ras1,
Ras2, Gpa2, Rho3, and Ycp4, continue to show ongoing,
residual palmitoylation in the 6-fold-deficient strain con-
text (Figure 4, row 8), similar to that seen in erf2D and
shr5D cells (Figure 4, rows 2 and 3).
The DHHC PAT Family
The DHHC proteins have emerged only recently as a pos-
sible family of PATs (Lobo et al., 2002; Roth et al., 2002).
While the past year has seen a variety of different mamma-
lian and yeast DHHC proteins linked to different palmi-
toylations (Ducker et al., 2004; Fukata et al., 2004; Hou
et al., 2005; Huang et al., 2004; Keller et al., 2004; Smotrys
et al., 2005; Swarthout et al., 2005; Valdez-Taubas and
Pelham, 2005), the overall extent of the role of this family
in palmitoylation has also been called into question by in
vitro demonstrations of DHHC protein-independent pal-
mitoylation (Dietrich et al., 2004; Dietrich and Ungermann,
2004), including apparently bona fide palmitoylations that
proceed in vitro fully nonenzymatically, through direct
chemical reaction of acceptor thiols with palmitoyl-CoA
(Duncan and Gilman, 1996; Leventis et al., 1997; Veit,
2000). Our analysis of multiply DHHC protein-deficient
strains, including two strains each deficient for six of the
seven yeast DHHC proteins, highlights DHHC protein par-
ticipations in the palmitoylation of 29 of the 30 palmitoyl
proteins surveyed by this analysis (Figure 4), indicating
that the DHHC PATs clearly mediate the bulk of the palmi-
toylation within the yeast cell.
Nonetheless, for some of the proteins, substantial pal-
mitoylation persists even in strains multiply deficient for
the DHHC proteins. For instance, five of the putative
Erf2-Shr5 substrates, namely Ras1, Ras2, Rho3, Gpa2,
and Ycp4, show reduced palmitoylation in erf2D cells
that is not further diminished with disruption of five of
the six other DHHC functions (Figure 4, row 8). The Erf2-
Shr5-independent activity responsible for the residual
palmitoylation of these five palmitoyl proteins remains un-
clear. Unfortunately, due to technical obstacles, we have
been unable to profile strains fully deficient for all seven
DHHC proteins; thus, the residual palmitoylation could still
possibly reflect overlapping DHHC PAT action. However,
it is also possible that the residual palmitoylation of these
partial Erf2-Shr5 substrates is DHHCprotein independent,
mediated either by yet to be discovered non-DHHC PATs
or perhaps by nonenzymatic mechanisms.
One protein, Bet3, shows a palmitoylation that is notably
undiminished in any of the different DHHC mutant strains
(Figure 4). Bet3 is a component of the TRAPP tethering
complex for ER-to-Golgi trafficking, and its palmitoylation
is noteworthy in other regards as well. The Bet3 palmitoyl
modification was discerned from recent crystallographic
structural analyses (Kim et al., 2005; Turnbull et al.,
2005). Interestingly, the attached acyl chain, rather than
being disposed as a possible tether, was found instead
to be oriented inwards, being entirely buried within
a close-fitting hydrophobic pocket of the protein. Further-
more, mutation of the cysteinyl acceptor site affects
neither Bet3 functionality nor Bet3 capacity for peripheral
association with its resident Golgi membranes. The acyl-
ated Bet3 for the two structural studies that reported
palmitoylation was purified from either yeast (Turnbull
et al., 2005) or overproducing E. coli (Kim et al., 2005).
For E. coli-produced Bet3, three forms were reported:
a nonacylated form as well as forms having either the
16-carbon palmitoyl or the 14-carbon myristoyl moiety
attached to Cys80 in thioester linkage. The finding of pro-
tein acylation occurring in E. coli is a bit surprising: Bacte-
ria lack both DHHC proteins as well as any evidence for
protein acyl modifications similar to protein palmitoylation
that is prevalent in eukaryotes. Might Bet3 palmitoylation
be autocatalytic? This could explain both the acylation of
Bet3 in bacteria and also the DHHC PAT-independent
palmitoylation that we now document for Bet3 (Figure 4).
Palmitoyl-CoA, we note, if fitted into the deep acyl binding
pocket of Bet3, would be nicely positioned for direct reac-
tion with the acceptor cysteine that locates at the mouth
of the hydrophobic pocket on the Bet3 surface.
Overall, we find that substrates of the DHHC PATs tend
to group by obvious common features. For instance, the
putative Swf1 substrates—a group that includes the pal-
mitoylated SNAREs as well as Mnn1, Mnn10, Mnn11,
and Pin2—all have cysteines that map cytoplasmically ad-
jacent to TMDs (Figure 2). Likewise, we identify Pfa4 as
a new member of the DHHC PAT family that is apparently
devoted to palmitoylation of the AAPs, a family of plasma-
membrane transporters with 12 TMDs and a conserved C-
terminal Phe-Trp-Cys palmitoylation site (Figure 3A and
Figure 6B). Erf2-Shr5 substrates all appear to be heteroli-
pidated, being either prenylated or myristoylated in addi-tion to being palmitoylated (Figure 5B), and Akr1 sub-
strates tend to be hydrophilic proteins that tether to
membranes solely through N- or C-terminal palmitoyl
modifications (Figure 5A). We conclude that the DHHC
protein family is a family of both discrete and overlapping
PAT specificities—a diverse range of specificities that to-
gether mediate the bulk of the diverse palmitoylations that
occur within the eukaryotic cell.
EXPERIMENTAL PROCEDURES
Strains
Strains isogenic to LRB759 (Panek et al., 1997) were utilized through-
out, except for the testing of putative Erf2 substrates (Figure 5B) and
the DHHC protein dependence of AAP palmitoylation (Figure 6), which
utilized Yeast Deletion Consortium strains (ResGen/Invitrogen) (see
Table S4 for complete strain list). The construction of the multiply
DHHC gene-deleted strains is described in the Supplemental Experi-
mental Procedures.
Purification of Palmitoyl Proteins for MS Analysis
Protein extracts derived from total membranes of 60 3 109 log-phase
yeast cells grown in YEPD were subjected to the three chemical treat-
ment steps of the acyl-biotinyl exchange (ABE) protocol (see Supple-
mental Experimental Procedures). Protein was transferred between
chemical treatment steps by collecting proteins at the conclusion of
one treatment step by chloroform-methanol precipitation (Wessel
and Flugge, 1984), which was followed by a 10 min, 37ºC resolubiliza-
tion and denaturation in SB (4%SDS, 50mMTris, 5mMEDTA [pH 7.4])
and then a 4-fold dilution into the chemicals comprising the next treat-
ment step. Proteins biotinylated by ABE were bound to streptavidin
agarose, washed with buffer, and eluted through cleavage of the
cysteine-biotin disulfide linkage with 1% b-mercaptoethanol.
Mass Spectrometry/MudPIT
Purified palmitoyl proteins were reduced with 5 mM TCEP (Pierce), al-
kylated with 10 mM iodoacetamide, and proteolyzed with endo-LysC
and trypsin. Peptides resolved by the in-line 2D-chromatographic sep-
aration steps that characterize MudPIT (Link et al., 1999; Washburn
et al., 2001) were introduced as they eluted from the microcapillary
columns over an 8 hr period directly into a LTQ ion tandem mass
spectrometer (Thermo Finnigan). Peptide identifications were made by
SEQUEST (Eng et al., 1994) correlation of tandem mass spectrometry
data to theoretical spectra derived from the translated Saccharomyces
Genome Database (SGD; 05/23/03 release) (Cherry et al., 1998). For
additional detail, see Supplemental Experimental Procedures.
Testing Palmitoylation for Individual Proteins
To confirm candidate protein palmitoylation and also DHHC protein
dependencies, epitope-tagged versions of individual proteins were
tested for palmitoylation. ORFs for the tested proteins were amplified
from yeast genomic DNA to GAL1-driven expression plasmids based
on pRS316 (CEN/ARS/URA3) that attached either a HA/FLAG dual
epitope tag to the N terminus or a 33 HA/FLAG tag to the C terminus.
Following a period of galactose-induced expression, palmitoylation
was assessed either through analysis of in vivo [3H]palmitate incorpo-
ration (Roth et al., 2002) or with a scaled-down version of the ABE
proteomic protocol. For additional detail, see Supplemental Experi-
mental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
one figure, four tables, and Supplemental References and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/5/1003/DC1/.Cell 125, 1003–1013, June 2, 2006 ª2006 Elsevier Inc. 1011
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